Back

Safety and efficacy of oral anticoagulation discontinuation in high thromboembolic risk patients at long term follow-up after successful atrial fibrillation ablation

31 August 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 3 - Atrial fibrillation ablation - Results from large cohorts Catheter Ablation of Arrhythmias ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Sakis Themistoclakis

Hospital of the Angelo Mestre, Venice (Italy)

9 More presentations in this session

Presentation thumbnail
Safety of atrial fibrillation catheter ablation in the elderly
Doctor N. Karim (London, GB)
Abstract
Presentation thumbnail
Outcomes of catheter ablation for atrial fibrillation based on sex: data from the cabana trial
Assistant Professor K. Monahan (Rochester, US)
Abstract Slides
Presentation thumbnail
Diagnostic yield of holter recording after atrial fibrillation ablation - detection of asymptomatic recurrences during a one-year follow-up period
Mr S. van Vugt (Nijmegen, NL)
Abstract
Presentation thumbnail
Feasibility and safety of same day discharge after radiofrequency catheter ablation for paroxysmal atrial fibrillation
Doctor A. Rajendra (Birmingham, US)
Abstract Slides
Presentation thumbnail
Role of pre-procedural CT-imaging on catheter ablation in patients with atrial fibrillation: procedural outcomes and radiological exposure.
Doctor A. Di Cori (Pisa, IT)
Abstract

Access the full session

Session thumbnail
Poster Session 3 - Atrial fibrillation ablation - Results from large cohorts

The Event

Event poster

ESC Congress 2019

31 August - 4 September 2019

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources